Ashish M. Ingle

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

Yaël P. Mossé, Megan S. Lim, Stephan D. Voss et al. · The Lancet Oncology · 2013 · 701 citations · Full text

Medicine, Oncology, Pediatrics +11

Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study

Julia Glade Bender, Peter C. Adamson, Joel M. Reid et al. · Journal of Clinical Oncology · 2008 · 251 citations

Pharmacy, Oncology, Pharmacology +16

Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report

Maryam Fouladi, Julie R. Park, Clinton F. Stewart et al. · Journal of Clinical Oncology · 2010 · 200 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group

Suman Malempati, Brenda J. Weigel, Ashish M. Ingle et al. · Journal of Clinical Oncology · 2011 · 178 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

Julia Glade Bender, Alice Lee, Joel M. Reid et al. · Journal of Clinical Oncology · 2013 · 164 citations · Full text

Pharmacy, Oncology, Pharmacology +17